Default company panoramic image

Sevo Nutraceuticals

Dietary supplement for improved brain health ready to launch. Studies show improves brain age and reduces symptoms of dementia, Alzheimers.

  • Stage Concept Only
  • Industry Consumer Products
  • Location Boston, MA, USA
  • Currency USD

Company Summary

Sevo brings science-based products to market, filling a need for products with supportable claims. Percepta, Sevo’s first product, is the result of 15 years of research and has been shown to reduce symptoms of dementia and improve cognition in healthy adults. Benefits include cost savings associated with reduced levels of care for Alzheimer's patients and allowing aging baby boomers to maintain mental acuity as they age.


  • Default avatar
    Bernie Prusaczyk

    Experienced entrepreneur with over 25 years’ experience in leadership, sales, marketing and business development. At core of several start-ups, managing from pre-revenue through rapid revenue and exit. Grew Agfa division (now Monotype Imaging) from $30MM. Grew NuGenesis Technologies from $0 to $25MM and successful sale to Waters Corporation.